The drug is composed of a humanised monoclonal antibody that binds to human CD19, internalising into the cell where enzymes release the PBD-based warhead.
Researchers recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.
CdS nanocrystals reversibly transition between ‘wurtzite-like’ and ‘zinc blende-like’ forms in a single step.
The destruction of a single kind of insulin-producing cell in the pancreas can lead to diabetes — but a study suggests that other cells could be modified to take its place and help to control blood sugar levels.
The decision came down to 14 yes votes, two no votes and one abstain, basing their support on the safety and efficacy data from five Phase III studies in patients with treatment-resistant depression: three short-term studies; one maintenance of effect study; and one long-term safety study.
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.
Laser-induced graphene combines with many materials to make tough, conductive composites for wearable electronics, anti-icing, antimicrobial applications, sensors and water treatment.
Researchers have reported new findings about perovskite solar cells that could lead the way to devices that perform better.
Theoretical new material bests graphene by some measures, but critics wonder if it can be made
An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 2 diabetes have to give themselves every day.